Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone coaching and app help adults lower heart risk

NCT ID NCT07393646

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a digital health program that combines online tools and phone coaching to help adults adopt healthier habits and prevent heart disease. Over 2,600 participants used the program for at least one year. Researchers measured changes in cardiovascular risk, physical activity, and diet to see if the program helped improve health behaviors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,688 people

The number who actually took part.

Started

Jul 2018

Finished

May 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Voluntary enrollment in the digital prevention program. * Access to digital devices (computer, tablet, or smartphone) to use the digital platform. * Consent to participate in the program and allow the use of data for research purposes. * For the analysis cohort: at least one year of participation in the program. * Insured people of MGEN health insurance Exclusion Criteria: * Participants who did not provide consent for the use of their data in research. * Participants with incomplete baseline cardiovascular risk data. * Participants who withdrew from the program before one year of participation. * Participants without follow-up data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular disease prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity Risk Reduction Behavior Sedentary Behavior cardiovascular disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vivoptim Solutions

    Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.